Abstract
Objective : The emergence of penicillin resistant strains and the presence of co-pathogens have made the treatment of bacterial infections in children a challenge. Streptococcal tonsillopharyngitis, which is a common infection has been well treated with cefprozil, a novel third generation cephalosporin. The aim of the present study was to evaluate cefprozil in pediatric tonsillopharyngitis. An assessment of the clinical cure and bacteriological eradication rates and an overall tolerability was made.Methods : It was a prospective, open, non-comparative multicentric study. 316 children (mean age 6.61 years) with tonsillopharyngitis were included. Patients were given cefprozil susp 15 mg/kg/day in two divided doses a day for 10 days.Results : A clinical cure of 96.6% and bacteriological eradication of 94.29% was achieved with cefprozil. Overall tolerability of cefprozil was assessed by physicians and 46% rated tolerability of cefprozil as excellent, 38% as very good, 10% as good, 6% as fair and none as poor.Conclusion : Cefprozil has been found to be an excellent drug of superior microbiological and clinical activity in the treatment of pediatric patients with tonsillopharyngitis. The drug also has an expanded spectrum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Milatovic D, Adam D, Hamilton H, Materman E. Cefprozil versus penicillin V in the treatment of streptococcal tonsillopharyngitis.Antimicrob Agents Chemother 1993; 37: 1620–1623.
Sinkinson CA, Pichichero ME, Centor RM. The compromises of managing acute pharyngitis.Emerg Med 1988; 9:161–68.
Gastanaduy AS, Kaplan EL, Huwe BBet al. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis.Lancet 1980; 11:498–501.
Brook L. The role of β lactamase producing bacteria in the persistence of streptococcal bacterial infection.Rev Infect Dis 1984; 6:601–607.
Wiseman LR, Benfield P. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.Drugs 1993; 45(2): 295–317.
De la Garza CA, Nolen TM, Rogan MP. Cefprozil vs. erythromycin in streptococcal tonsillopharyngitis.Infections in Medicine 1992; 9(Suppl E): 8–20.
Barbarash RA, Solomon E, Thieneman Jr. A, Stricker WE, Scott JCet al. Cefprozil versus amoxicillin/clavulanate in mild to moderate lower respiratory tract infections.Infections in Medicine 1992; 9(Suppl E): 40–47.
Wilber RB, Hamilton H, Leroy A, Gres J, Durham SJet al. Cefprozil vs. cefaclor in the treatment of lower respiratory tract infections.Infections in Medicine 1992; 9(Suppl C): 45–46.
Solomon E, McCarty JM, Morman MR, Ginsberg D, Nolen TM,et al. Comparison of cefprozil and amoxicillin/clavulanate potassium in the treatment of skin and skin structure infections in adults.Advances in Therapy 1992; 9:156–165.
Iravani A, Doyle CA, Durham SJ, Wilber RB. The Cefprozil Multicentre Study Group. Cefprozil vs. cefaclor in the treatment of acute and uncomplicated urinary tract infections.Clinical Therapeutics 1992; 14:314–326.
Barbhaiya RH, Shukla UA, Gleason CRet al. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.Antimicrob Agents Chemother 1990; 34:1204–1209.
R.Brooks GH, Morgantown WV. Cefprozil, A new cephalosporin: Its use in various clinical trials.Southern Medical Journal 1995; 88(3): 338–346.
Gerson A. Treatment of upper and lower respiratory tract infections: clinical trials with cefprozil.Pediatr Inf Dis J 1987; 17: S83–88.
Ginsburgh CM, McCracken GH, Crow SD, Steinberg JB, Cpoe F. A controlled comparative study of penicillin V and cefadroxil therapy of group A streptococcal tonsillopharyngitis.J Int Med Res 1980; 8(suppl 1): 82–86.
Hennes DM. A clinical experience with cefadroxil in upper respiratory tract infection.J Antimicrob Chemother 1982; 10 (Suppl B):125–35.
De La Garza CA, Nolen TM, Rogan MP. Cefprozil vs. cefaclor in streptococcal tonsillopharyngitis.Infect Med 1992; 9(Suppl E): 8–20.
Doyle CA, Durham SJ, Hamilton HA, Wilber RB. Cefprozil vs. cefaclor in the treatment of pharyngitis and tonsillitis in adults.Infect Med 1992; 9(Suppl E): 66–7.
Sackett DL and Haynes RB, eds.Compliance with Therapeutic Regimens. Baltimore, MD. Johns Hopkins University Press, 1976; 293p.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, N., Mukherjee, A. & Moharana, A.K. Pediatric tonsillopharyngitis — an evaluation of cefprozil in Indian patients. Indian J Pediatr 71, 601–605 (2004). https://doi.org/10.1007/BF02724119
Issue Date:
DOI: https://doi.org/10.1007/BF02724119